Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer
NCT00136526
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Docetaxel and Diethylstilbestrol (DES)
Sponsor
University of Washington
Collaborators
[object Object]